Evidence map›Paper›PMID 38004410›Full record

ArticlePharmaceuticals (Basel, Switzerland)2023

Optimization of Automated Radiosynthesis of Gallium-68-Labeled PSMA11 with Two [

Flore Durieux, Bérengère Dekyndt, Jean-François Legrand, Antoine Rogeau, Emmanuel Malek, Franck Semah, Pascal Odou

Open access · goldAbstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Diagnostic efficacy of [BMC cancer · 2024
    Pooled it
  2. Article
  3. ExpandingEJNMMI radiopharmacy and chemistry · 2026
    Article
  4. ScalableWorld journal of nuclear medicine · 2026
    Article
  5. Article
  6. Article
  7. [Frontiers in medicine · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Flore DurieuxInstitute of Pharmacy, CHU Lille, F-59000 Lille, France.
Bérengère DekyndtInstitute of Pharmacy, CHU Lille, F-59000 Lille, France.
Jean-François LegrandInstitute of Pharmacy, CHU Lille, F-59000 Lille, France.ORCID 0009-0001-2225-1746
Antoine RogeauNuclear Medicine Department, CHU Lille, F-59000 Lille, France.ORCID 0000-0002-3993-3954
Emmanuel MalekRadiopharmacy Unit-Institute of Pharmacy, CH Valenciennes, F-59300 Valenciennes, France.
Franck SemahNuclear Medicine Department, CHU Lille, F-59000 Lille, France.
Pascal OdouInstitute of Pharmacy, CHU Lille, F-59000 Lille, France.
Centre Hospitalier Universitaire de Lille · FRUniversité de Lille · FRCentre Hospitalier de Valenciennes · FRInserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Prostate cancer is one of the most common forms of cancer in men. An imaging technique for its diagnosis is [

Indexed as

[68Ga]Ga-PSMA-11double elutionradiopharmacy

Identifiers

PMID38004410
PMCPMC10674510
OpenAlexW4388140398

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.